MBX Biosciences, Inc. Common Stock

NASDAQ: MBX · Healthcare · Biotechnology

PublicHQ Carmel, IN · HamiltonCIK 0001776111Reports USD

#1 of 1,422 Healthcare companies by revenue

EA Score

——

FH 70DQ —GM —SS 77

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, Altman-Z · ↓ Piotroski F, workforce scale

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$87.0M

Employees

as of 2026-08-09

Market cap

$3.2B

as of 2026-08-09

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$87.0M-$87.0M2025

Operating income-$98.1M-$98.1M2025

Total assets$385.1M$385.1M2025

Liabilities$15.9M$15.9M2025

Equity$369.2M$369.2M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is MBX Biosciences, Inc. Common Stock’s financial profile?

MBX Biosciences, Inc. Common Stock earned -$87.0M in FY2025 net income.

Peers · Healthcare

Legend Biotech Corporation——Galera Therapeutics, Inc.——Vicore Pharma Holding AB——Structure Therapeutics Inc.——Disc Medicine, Inc.——Kodiak Sciences Inc.——

Neighbors

Hamilton →

CNO Financial Group, Inc.$4.5B67B OPENLANE, Inc.$1.9B64C Merchants Bancorp——American Resources Corporation$051D First Internet Bancorp$11.5M31D NeurAxis, Inc.$3.6M45D

Key facts

CEOSteve Hoerter

SectorHealthcare

IndustryBiotechnology

HeadquartersCarmel, IN

ExchangeNASDAQ: MBX

Employees63

IPO date2000-01-14

Latest filings

8-K2026-08-27 10-Q2026-08-06 8-K2026-08-06 8-K2026-07-13 8-K2026-06-12 8-K2026-06-05 8-K2026-05-11 8-K2026-05-07

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.